Mckesson Medical-Surgical Inc. has recalled 18 units of Medroxyprogesterone Acetate (medroxyprogesterone) and Infuvite Adult (multiple vitamins) injections. These cold chain products were shipped on April 2, 2025, but were delayed by severe thunderstorms and delivered five to six days later, exceeding the required 48-hour delivery window. Because the products were not kept at the recommended cold temperatures during this delay, their safety, quality, and effectiveness may be compromised.
The affected medications may not have been stored at the required temperatures, which can impact the medicine's potency, purity, and safety. Using compromised injectable medications could result in less effective treatment or other health risks.
Manufactured for Eugia US LLC.
Manufactured for Sandoz Inc.; Distributed by Baxter Healthcare Corporation.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.